Independent Advisor Alliance Anavex Life Sciences Corp. Transaction History
Independent Advisor Alliance
- $2.95 Billion
- Q1 2025
A detailed history of Independent Advisor Alliance transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Independent Advisor Alliance holds 46,554 shares of AVXL stock, worth $528,853. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,554
Previous 46,554
-0.0%
Holding current value
$528,853
Previous $499,000
20.04%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AVXL
# of Institutions
199Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$72.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$55.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$36.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$22.3 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$11.4 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $885M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...